Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Provenge in metastatic androgen-independent prostate cancer (IMPACT)
NCT00065442Phase 3Completed
- Sponsor
- Dendreon
- Start
- Jul 2003
- Primary completion
- Jan 2009
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 3 trial of sipuleucel-T in prostate cancer (PCa), sponsored by Dendreon. Started Jul 2003; status: completed.
02
Drugs
sipuleucel-T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00065442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065442.